COVID-19 treatment

October 31, 2022

COVID-19 Guideline Revisions & Updates – Important updates to guidelines such as pre-procedure testing and clinical guidelines

By VUMC News and Communications
October 6, 2022

Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America

Vanderbilt’s James Crowe Jr., MD, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization.

By Bill Snyder
July 7, 2022

Convalescent plasma doesn’t help severely ill COVID patients: study

A Vanderbilt clinical trial shows that convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover

By Nancy Humphrey
June 27, 2022

Occupational Health offers tips to kick off summer on a healthy note

We are officially into summer, which means vacations are ramping up. As you write your checklist, pack your suitcase, and book your trip, here are few important reminders.

By Wayne Wood
June 16, 2022

VUMC research aids approval of COVID-19 vaccine for young children

The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old as early as tomorrow, following the unanimous recommendation by an FDA advisory panel on Wednesday.

By Bill Snyder
Dolly Parton and longtime friend, Naji Abumrad, MD. (photo Courtesy of Dolly Parton)
June 15, 2022

Dolly Parton donates $1 million to pediatric infectious disease research at Vanderbilt University Medical Center

Dolly Parton is donating $1 million to pediatric infectious disease research at Vanderbilt University Medical Center to help in the fight against serious infectious diseases such as coronavirus that have worldwide ramifications.

By Craig Boerner
June 2, 2022

Study explores positioning options to improve COVID mortality

Vanderbilt researchers found that prone positioning of patients with COVID-19-related hypoxemia not on mechanical ventilation offered no observed clinical benefit among these patients.
By Nancy Humphrey
May 16, 2022

Multiple outpatient treatment options for COVID-19, including Paxlovid™

By Kylie Avery
May 10, 2022

Resistance to COVID-19 drug detected in lab study

Vanderbilt research shows that the virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.  
By Bill Snyder
April 6, 2022

Major grant renewal to provide five more years of support for VICTR

Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health.
By Bill Snyder
March 31, 2022

Crowe receives national award for COVID antibody research

Vanderbilt's James Crowe Jr., MD, and Michel Nussenzweig, MD, PhD, of The Rockefeller University, have been jointly awarded the 2022 Harrington Prize for Innovation in Medicine for “groundbreaking work” that enabled the use of human antibodies to treat COVID-19.
By Bill Snyder
March 30, 2022

Uncharted days of the COVID-19 pandemic strengthen the Vanderbilt Vaccine Research Program team.

“There’s something about having a band of brothers, where you’re all focused on the same thing, and your noses are all pointed in the same direction."
By Jill Clendening
March 30, 2022

Team helps patients battle post-COVID cognitive issues

Jane Stories is one of many COVID-19 patients still plagued by debilitating symptoms that include achy muscles, anxiety, depression, panic attacks and cognitive impairment.
By Bill Snyder and Nancy Humphrey